A Varegacestat Hepatic Impairment Study

Completed · Phase 1

Conditions studied: Healthy Volunteer, Hepatic Impairment (HI)

In brief

This clinical trial is designed to determine the pharmacokinetics, safety and tolerability of varegacestat in people with impaired liver function compared to people with normal liver function.

Key facts

Study ID

NCT06841315

Run by

Immunome, Inc.

People needed

35

Starts

2025-03-07

Expected to finish

2026-03-06

Last updated by the study team

2026-03-10

Who can join

Age: 18 and older, up to 84. Sex: any. Healthy volunteers: accepted.

Where it is running

• Orlando Clinical Research Center — Orlando, Florida, United States
• The Texas Liver Institute — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.